Profilo
Valeria Cnossen is currently the Executive Vice President & General Counsel at Galapagos NV.
Prior to her current position, she served as the Head-Legal & Compliance at Crucell NV and as the General Counsel-Consumer Health Group at Johnson & Johnson Consumer NV.
Posizioni attive di Valeria Cnossen
Società | Posizione | Inizio |
---|---|---|
GALAPAGOS NV | General Counsel | 01/01/2023 |
Precedenti posizioni note di Valeria Cnossen
Società | Posizione | Fine |
---|---|---|
Johnson & Johnson Consumer NV | Corporate Officer/Principal | - |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Compliance Officer | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
GALAPAGOS NV | Health Technology |
Aziende private | 2 |
---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Johnson & Johnson Consumer NV |
- Borsa valori
- Insiders
- Valeria Cnossen